Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis

BACKGROUND: The clinical implication of plasma ESR1 mutations in the estrogen receptor (ER)-positive metastatic breast cancer (MBC) patients who had progressed after prior aromatase inhibitor (AI)-based therapy remains controversial. We conducted the first meta-analysis to investigate the prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kai, Hong, Ruoxi, Xu, Fei, Xia, Wen, Kaping, Lee, Qin, Ge, Zheng, Qiufan, Lu, Qianyi, Shi, Yan Xia, Yuan, Zhong Yu, Wang, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097501/
https://www.ncbi.nlm.nih.gov/pubmed/30147360
http://dx.doi.org/10.2147/CMAR.S173193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097501/
https://www.ncbi.nlm.nih.gov/pubmed/30147360
http://dx.doi.org/10.2147/CMAR.S173193

Ejemplares similares